{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:43:24Z","timestamp":1776915804705,"version":"3.51.2"},"publisher-location":"Cham","reference-count":42,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319600147","type":"print"},{"value":"9783319600161","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/7854_2015_424","type":"book-chapter","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T05:13:29Z","timestamp":1450761209000},"page":"125-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics"],"prefix":"10.1007","author":[{"given":"Mark E.","family":"Montebello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Brett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"424_CR1","unstructured":"Australia Co (2013) National pharmaceutical drug misuse framework for action (2012\u20132015)"},{"key":"424_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0196-0644(03)00600-0","volume":"42","author":"CR Balit","year":"2003","unstructured":"Balit CR, Isbister GK, Hackett LP, Whyte IM (2003) Quetiapine poisoning: a case series. Ann Emerg Med 42:751\u2013758","journal-title":"Ann Emerg Med"},{"key":"424_CR3","first-page":"77","volume":"10","author":"GT Bogart","year":"2011","unstructured":"Bogart GT, Ott CA (2011) Abuse of second-generation antipsychotics: what prescribers need to know. Curr Psychiatry 10:77\u201379","journal-title":"Curr Psychiatry"},{"issue":"8","key":"424_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5694\/mja14.01116","volume":"202","author":"N Buckley","year":"2015","unstructured":"Buckley N, Whyte IM, Dawson AH, Isbister GK (2015) 26\u00a0Years of self-poisoning in Newcastle, 1987\u20132012. Aust Med J 202(8):438\u2013442","journal-title":"Aust Med J"},{"key":"424_CR5","unstructured":"Crime UNOoDa (2011) The non-medical use of prescription drugs. In: Policy direction issues discussion paper. United Nations Office on Drugs and Crime, New York"},{"key":"424_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/14659891.2013.810309","volume":"19","author":"WJ Cubala","year":"2014","unstructured":"Cubala WJ, Springer J (2014) Quetiapine abuse and dependence in psychiatric patients: a treatment. J Subst Use 19:388\u2013393","journal-title":"J Subst Use"},{"key":"424_CR7","unstructured":"Health AGDo (2015) Schedule of pharmaceutical benefits. Australian Capital Territory: Commonwealth of Australia"},{"key":"424_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/dar.12028","volume":"32","author":"CE Heilbronn","year":"2013","unstructured":"Heilbronn CE, Lloyd B, McElwee P, Eade A, Lubman DI (2013) Trends in quetapine use and non-fatal quetiapine-related ambulance attendances. Drug Alcohol Rev 32:405\u2013411","journal-title":"Drug Alcohol Rev"},{"key":"424_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/00048670903489890","volume":"44","author":"SA Hollingworth","year":"2010","unstructured":"Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD (2010) Patterns of antipsychotic medication use in Australia 2002\u20132007. Aust NZJ Psychiatry 44:372\u2013377","journal-title":"Aust NZJ Psychiatry"},{"key":"424_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/1039856214530015","volume":"22","author":"M Huthwaite","year":"2014","unstructured":"Huthwaite M, Cleghorn M, MacDonald J (2014) \u2018Out of the frying pan\u2019: the challenges of prescribing for insomnia in psychiatric patients. Australas Psychiatry 22:288\u2013291","journal-title":"Australas Psychiatry"},{"key":"424_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/YIC.0b013e32832bb078","volume":"24","author":"GK Isbister","year":"2009","unstructured":"Isbister GK, Duffull SB (2009) Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol 24:174\u2013180","journal-title":"Int Clin Psychopharmacol"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Walters EE (2005) Prevalence, severity and comorbidity of 12-Month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:617\u2013627","journal-title":"Arch Gen Psychiatry"},{"key":"424_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ADM.0000000000000020","volume":"8","author":"W Klein-Schwartz","year":"2014","unstructured":"Klein-Schwartz W, Schwartz EK, Anderson BD (2014) Evaluation of quetiapine abuse and misuse reported to poison centers. J Addict Med 8:195\u2013198","journal-title":"J Addict Med"},{"key":"424_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/08897077.2012.709222","volume":"34","author":"NA Kumsar","year":"2013","unstructured":"Kumsar NA, Erol A (2013) Olanzapine abuse. Subst Abuse 34:73\u201374","journal-title":"Subst Abuse"},{"key":"424_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0079-6123(08)00910-2","volume":"172","author":"T Kuroki","year":"2008","unstructured":"Kuroki T, Nagao N, Nakahara T (2008) Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Prog Brain Res 172:199\u2013212","journal-title":"Prog Brain Res"},{"key":"424_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.pnpbp.2010.07.031","volume":"34","author":"CH Lai","year":"2010","unstructured":"Lai CH (2010) Olanzapine abuse was relieved after switching to aripiprazole in a patient with psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 34:1363\u20131364","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"424_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jsat.2014.07.006","volume":"48","author":"T Malekshahi","year":"2015","unstructured":"Malekshahi T, Tioleco N, Ahmed N, Campbell ANC, Haller D (2015) Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse. J Subst Abuse Treat 48:8\u201312","journal-title":"J Subst Abuse Treat"},{"key":"424_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","volume":"26","author":"A McKean","year":"2012","unstructured":"McKean A, Monasterio E (2012) Off-label use of atypical antipsychotics: cause for concern? CNS Drugs 26:383\u2013390","journal-title":"CNS Drugs"},{"key":"424_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/JCP.0b013e3182670648","volume":"32","author":"ME McLarnon","year":"2012","unstructured":"McLarnon ME, Fulton HG, MacIsaac C, Barrett SP (2012) Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program. J Clin Psychopharmacol 32:721\u2013723","journal-title":"J Clin Psychopharmacol"},{"key":"424_CR20","unstructured":"Milligan L (2013) Concerns grow over top-selling drug\u2019s side effects. In: Corporation AB (ed) 730 Report: ABC"},{"key":"424_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/02791072.2013.845328","volume":"45","author":"J Moncrieff","year":"2013","unstructured":"Moncrieff J, Cohen D, Porter S (2013) The psychoactive effects of psychiatric medication: the elephant in the room. J Psychoactive Drugs 45:409\u2013415","journal-title":"J Psychoactive Drugs"},{"key":"424_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1360-0443.2011.03686.x","volume":"107","author":"M Nielsen","year":"2012","unstructured":"Nielsen M, Hansen EH, G\u00f8tzsche PC (2012) What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. Addiction 107:900\u2013908","journal-title":"Addiction"},{"key":"424_CR23","first-page":"517","volume":"12","author":"SD Passik","year":"1998","unstructured":"Passik SD, Portenoy RK, Ricketts PL (1998a) Substance abuse issues in cancer patients. Part 1: prevalence and diagnosis. Oncology 12:517\u2013521","journal-title":"Oncology"},{"key":"424_CR24","first-page":"729","volume":"12","author":"SD Passik","year":"1998","unstructured":"Passik SD, Portenoy RK, Ricketts PL (1998b) Substance abuse issues in cancer patients. Part 2: evaluation and treatment. Oncology 12:729\u2013734","journal-title":"Oncology"},{"key":"424_CR25","unstructured":"PBS Schedule search for \u201cQUETIAPINE\u201d (2015) Commonwealth of Australia. Accessed 12\/02\/2015, at http:\/\/www.pbs.gov.au\/pbs\/search?term=QUETIAPINE"},{"key":"424_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12024-012-9404-4","volume":"9","author":"JL Pilgrim","year":"2013","unstructured":"Pilgrim JL, Drummer OH (2013) The toxicity and comorbidities of fatal cases involving quetiapine. Forensic Sci Med Pathol 9:170\u2013176","journal-title":"Forensic Sci Med Pathol"},{"key":"424_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/add.12395","volume":"109","author":"SE Reddel","year":"2014","unstructured":"Reddel SE, Bruno R, Burns L, Kirwan A, Lukuge K, Dietze P (2014) Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs. Addiction 109:295\u2013302","journal-title":"Addiction"},{"key":"424_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/02791072.2007.10400617","volume":"39","author":"RR Reeves","year":"2007","unstructured":"Reeves RR (2007) Abuse of Olanzapine by substance users. J Psychoactive Drugs 39:297\u2013299","journal-title":"J Psychoactive Drugs"},{"key":"424_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1078345811421591","volume":"18","author":"R Reeves","year":"2012","unstructured":"Reeves R (2012) Guideline, education and peer comparison to reduce prescriptions of benzodiazepines and low-dose quetiapine in prison. J Corrective Health Care 18:45\u201352","journal-title":"J Corrective Health Care"},{"key":"424_CR30","first-page":"13","volume":"7","author":"RA Sansone","year":"2010","unstructured":"Sansone RA, Sansone LA (2010) Is seroquel developing an illicit reputation for misuse\/abuse? Psychiatry 7:13\u201316","journal-title":"Psychiatry"},{"key":"424_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/imj.12065","volume":"43","author":"IA Scott","year":"2013","unstructured":"Scott IA, Elshaug AG (2013) Foregoing low-value care: how much evidence is needed to change beliefs? Intern Med J 43:107\u2013109","journal-title":"Intern Med J"},{"key":"424_CR32","unstructured":"Seroquel (quetiapine fumarate) Tablets (2013) AstraZeneca Pharamceuticals LP. Accessed 14\/05\/2015, at http:\/\/www1.astrazeneca-us.com\/pi\/seroquel.pdf"},{"key":"424_CR33","unstructured":"Seroquel XR quetiapine fumarate Product Information. AstraZeneca, 2014. Accessed 14\/05\/2015, at http:\/\/www.medicines.org.au\/files\/appserxr.pdf"},{"key":"424_CR34","unstructured":"Service NP (2014) Low-dose quetiapine: place in therapy? Health News and Evidence: NPS Medicinewise"},{"key":"424_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.forsciint.2015.01.003","volume":"248","author":"KW Simonsen","year":"2015","unstructured":"Simonsen KW, Edvardsen HME et al (2015) Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 248:172\u2013180","journal-title":"Forensic Sci Int"},{"key":"424_CR36","first-page":"351","volume":"41","author":"JM Smith","year":"1980","unstructured":"Smith JM (1980) Abuse of the antiparkinson drugs: a review of the literature. J Clin Psychiatry 41:351\u2013354","journal-title":"J Clin Psychiatry"},{"key":"424_CR37","first-page":"152","volume":"16","author":"A Srivastava","year":"2013","unstructured":"Srivastava A, Patil V, Da Silva Pereira Y (2013) A case series of quetiapine addiction\/dependence. Ger J Psychiatry 16:152\u2013155","journal-title":"Ger J Psychiatry"},{"key":"424_CR38","unstructured":"Stafford J, Burns L (2014) Australian Drug Trends 2013. In: Findings from the illicit drug reporting system (IDRS). University of New South Wales, Australia"},{"key":"424_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0004867412466595","volume":"47","author":"CP Stephenson","year":"2012","unstructured":"Stephenson CP, Karanges E, McGregor IS (2012) Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust NZJ Psychiatry 47:74\u201387","journal-title":"Aust NZJ Psychiatry"},{"key":"424_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1517\/14740330802496883","volume":"7","author":"OV Tcheremissine","year":"2008","unstructured":"Tcheremissine OV (2008) Is quetiapine a drug of abuse? Re-examining the issueof addiction. Expert Opin Drug Safety 7:739\u2013748","journal-title":"Expert Opin Drug Safety"},{"key":"424_CR41","unstructured":"Welfare AIoHa (2013) National drug strategy household survey detailed report. Canberra"},{"key":"424_CR42","unstructured":"WHO (2015) Management of substance abuse. Accessed 28\/05\/2015, at http:\/\/www.who.int\/substance_abuse\/terminology\/definition1\/en\/"}],"container-title":["Current Topics in Behavioral Neurosciences","Non-medical and illicit use of psychoactive drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2015_424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T12:42:15Z","timestamp":1677069735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2015_424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319600147","9783319600161"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/7854_2015_424","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"23 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}